Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - Eloxx Pharmaceuticals, Inc. | elox-ex322_14.htm |
EX-32.1 - EX-32.1 - Eloxx Pharmaceuticals, Inc. | elox-ex321_10.htm |
EX-31.2 - EX-31.2 - Eloxx Pharmaceuticals, Inc. | elox-ex312_12.htm |
EX-31.1 - EX-31.1 - Eloxx Pharmaceuticals, Inc. | elox-ex311_11.htm |
EX-23.2 - EX-23.2 - Eloxx Pharmaceuticals, Inc. | elox-ex232_6.htm |
EX-23.1 - EX-23.1 - Eloxx Pharmaceuticals, Inc. | elox-ex231_7.htm |
EX-10.44 - EX-10.44 - Eloxx Pharmaceuticals, Inc. | elox-ex1044_293.htm |
EX-10.43 - EX-10.43 - Eloxx Pharmaceuticals, Inc. | elox-ex1043_294.htm |
EX-10.42 - EX-10.42 - Eloxx Pharmaceuticals, Inc. | elox-ex1042_295.htm |
10-K - 10-K - Eloxx Pharmaceuticals, Inc. | elox-10k_20191231.htm |
Exhibit 21.1
Subsidiaries of Eloxx Pharmaceuticals, Inc.
as of December 31, 2019
Eloxx Pharmaceuticals Ltd., a private limited company organized under the laws of Israel